Resmed Financial Overview
Resmed's market cap is currently $35.90B. The company's EPS TTM is $2.55; its P/E ratio is 25.17; and it has a dividend yield of 0.93%. Resmed is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $2.72. See an overview of income statement, balance sheet, and cash flow financials.
